Skip to main content
. 2015 May 6;47(1):71–80. doi: 10.3892/ijo.2015.2989

Figure 3.

Figure 3

Treatment with PD0325901 and temsirolimus inhibits tumor cell signaling. Subcutaneous tumorgrafts of cardiac canine AS non-treated or treated with vehicle, PD0325901, temsirolimus, or PD0325901 plus temsirolimus (PD+T) were stained for H&E and immunostained for CD31, pERK and pS6. Bar, 100 μm.